Mitchell Shawnte bought OLMA
March 4, 2026 · Form 4 insider transaction
Mitchell Shawnte bought 25,000 shares of Olema Pharmaceuticals, Inc. at $4.37 per share, a transaction worth $109.3K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
25,000
Price
$4.37
Total value
$109.3K
InsiderMitchell Shawnte
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 4, 2026
Filing dateMarch 5, 2026
Shares owned after25,000
OwnershipDirect
10b5-1 planNo
AmendedNo